NEFL and Alzheimer disease: Although p‐tau217 can accurately distinguish frontal AD from bvFTD, and NfL has strong diagnostic performance for bvFTD versus PPDs at group levels, our findings suggest that many individuals with bvFTD would still have non‐diagnostic biomarker levels and profiles.